|
|
Kingdom OKs Glaxo vaccine
- 9 Hours ago
|
|
|
|
RIYADH: British drugmaker GlaxoSmithKline is currently Saudi Arabias sole supplier of an H1N1 flu vaccine but the Kingdom may include other firms for the supply of a nationwide inoculation campaign, the
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pharma Outsourcing, 8-9 April 2010, Munich, Germany
- 9 Hours ago
|
|
|
|
ADMET.net| AgBio.net | BioInformatics.net | ClinicalTrials.net | CombiChem.net | ePosters.net | GenomicsNews.com | HTScreening.net | Lab-on-a-Chip.com | MarketReports.com | MassSpec.net | Metabolomics.net
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
FDA launches plan to curb accidental overdoses
- 2 Hours ago
|
|
|
|
Under the plan announced Wednesday, the FDA will work with physicians to identify the types of drugs that pose the greatest risks to patients. Proposals to improve safety include: simplifying drug labeling,
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Aurobindo drug gets US nod
- 2 Hours ago
|
|
|
|
Aurobindo Pharma Ltd has received final approval from the US Food and Drug Administration (USFDA) for Lamotrigine tablets.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TRW Reports Third Quarter 2009 Financial Results
- 110 Minutes ago
|
|
|
|
LIVONIA, Mich., Nov. 4 /PRNewswire-FirstCall/ -- TRW Automotive Holdings Corp. (NYSE: TRW), the global leader in active and passive safety systems, today reported third-quarter 2009 financial results
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Drugs that work and won't break the bank
- 4 Hours ago
|
|
|
|
Last year pharmaceutical companies spent more than $4 billion urging patients like you to â??ask your doctorâ? about their drugs. But if you want a prescription that wonâ??t empty your wallet, while
|
|
|
|
|
|
|
|
|
|
|
|
|
Sirius XM 3Q loss narrows as revenue rises
- 5 Hours ago
|
|
|
|
NEW YORK -- Sirius XM Radio Inc., the satellite radio provider that was on the brink of bankruptcy nine months ago, on Thursday reported a much improved third quarter as it signed up more subscribers
|
|
|
|
|
|
|
|
|
|
|
|
|
Elan, Biogen change Tysabri label due to PML risk
- 18 Hours ago
|
|
|
|
3:34pm GMT storyKeywords RTR_ArticleTitle 'Elan, Biogen change Tysabri label due to PML RTR_ArticleBlurb ' DUBLIN, Nov 7 (Reuters) Ireland's Elan (ELN.I) and U.S. drugmaker Biogen Idec (BIIB.O) have amended
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
*Votes may take up to 30 minutes to influence
article rank order |
|